AI-powered drug discovery: Accelerating the development of life-saving therapies
Supported by:
18 September 2025
1:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
AI in drug discovery is no longer theoretical. It’s already speeding up target identification, improving predictions, and cutting waste. Learn how to apply it in your own discovery pipeline.
Artificial intelligence is no longer a future promise – it is actively transforming the way new medicines are discovered, developed and brought to market. In this expert-led webinar, we explore how AI is reshaping early drug discovery, from target identification and compound screening to predictive modelling and trial design.
As research teams face growing pressure to improve efficiency, reduce costs, and accelerate timelines, AI offers powerful tools to tackle long-standing bottlenecks. But where is it making a real difference – and what does effective implementation actually look like?
Dr Remco Jan Geukes Foppen will share practical insights into how AI is being applied across the pharmaceutical sector, helping teams move faster and make better-informed decisions. With experience spanning data management, image analysis, bioinformatics, and machine learning in clinical research, he brings both deep technical expertise and strategic understanding of real-world challenges.
Key learning points:
- Learn how AI is accelerating early-stage drug discovery and improving target identification
- Explore real-world examples of AI delivering measurable impact in pharma and life sciences
- Discover practical strategies for applying AI effectively within your organisation
- Ask your questions live and benefit from expert insight during the Q&A session
Whether you work in biotech, pharma, data science, or translational research, this session will offer a clear view of how AI is being used across early discovery – and what it could mean for the future of your work.
Register your interest now. Attendance is free >>>
SPEAKER
Dr Remco Jan Geukes Foppen – International Commercial Leader in Artificial Intelligence and Life Sciences, Co-founder of Explainambiguity and Consultant at Regina Elena National Cancer Institute
Remco Jan Geukes Foppen, PhD, is an AI and life sciences expert specialising in the pharmaceutical sector. With a global perspective, he integrates and implements AI-driven strategies that impact business decisions, always considering the human element. His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Remco Jan Geukes Foppen’s academic background includes a PhD in biology and a master’s degree in chemistry, both from the University of Amsterdam.
FAQs
Is the webinar free?
Yes – there is no charge to watch the webinar, either live or on-demand.
When will the webinar take place?
The webinar will take place live on 18 September at 2pm BST
I’m busy. Can I watch it later?
The webinar will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
During the live webinar, you’ll be able to ask the speakers your questions, which will then be answered during the live Q&A session towards the end of the webinar.
How long will the webinar be?
This webinar will last for up to one hour.
What do I need to watch this webinar?
All you need is a computer with an internet connection. Be sure to use headphones if in an office environment.
Do I receive a certificate?
Yes, you will receive a certificate if you attend the webinar live. The certificate will be sent with your on-demand video link.
